Clinical Trials Browser

Interventional × Advanced Triple Negative Breast Cancer × ALT-803 × Clear all

NCT04927884 2024-06-12

A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies

Phase 1/2 Terminated

3 enrolled 9 charts

Advanced Triple Negative Breast Cancer